Novartis AG - Other Stockholder Equity

Novartis AG's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Other-Stockholder-Equity" stands at 0.378 Billion United States Dollars as of 09/30/2025, the highest value since 12/31/2012.

As of the end of Novartis AG's third quarter, the item "Other Stockholder Equity" stands at 0.378 Billion USD. This represents an increase of 982.38 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 0.2805 Billion United States Dollars compared to the value the year prior.
The 1 year change is 0.2805 Billion United States Dollars.
The 3 year change is 0.369 Billion United States Dollars.
The 5 year change is 0.3556 Billion United States Dollars.
The 10 year change is 0.305 Billion United States Dollars.

The Serie's long term average value is -0.354 Billion United States Dollars. It's latest available value, on 09/30/2025, is 0.732 Billion United States Dollars higher, compared to it's long term average value.
The Serie's change in United States Dollars from it's minimum value, on 12/31/2015, to it's latest available value, on 09/30/2025, is +80.78 Billion.
The Serie's change in United States Dollars from it's maximum value, on 09/30/2012, to it's latest available value, on 09/30/2025, is -66.83 Billion.